4//SEC Filing
Feider Stephen 4
Accession 0002048588-25-000003
CIK 0001674632other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:31 PM ET
Size
10.4 KB
Accession
0002048588-25-000003
Insider Transaction Report
Form 4
Feider Stephen
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-10-01$5.10/sh+15,018$76,592→ 59,059 total - Sale
Common Stock
2025-10-01$20.76/sh−14,918$309,698→ 44,141 total - Sale
Common Stock
2025-10-01$21.08/sh−100$2,108→ 44,041 total - Exercise/Conversion
Employee Stock Option (right to buy)
2025-10-01−15,018→ 74,677 totalExercise: $5.10Exp: 2033-09-13→ Common Stock (15,018 underlying)
Footnotes (3)
- [F1]Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025.
- [F2]The weighted average sale price for the transaction reported was $20.76 and the range of prices were between $20.03 and $21.03. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F3]The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.
Documents
Issuer
Beta Bionics, Inc.
CIK 0001674632
Entity typeother
Related Parties
1- filerCIK 0002048588
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 4:31 PM ET
- Size
- 10.4 KB